✦ LIBER ✦

Dickkopf-1 as a mediator and novel target in malignant bone disease

✍ Scribed by Rachner, Tilman D.; Göbel, Andy; Benad-Mehner, Peggy; Hofbauer, Lorenz C.; Rauner, Martina

Book ID: 122283604
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 925 KB
Volume: 346
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2014.01.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sclerostin and Dickkopf-1 as Therapeutic

Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases

✍ Ke, H. Z.; Richards, W. G.; Li, X.; Ominsky, M. S. 📂 Article 📅 2012 🏛 Endocrine Society 🌐 English ⚖ 774 KB

The Wnt inhibitor dickkopf-1: A novel ta

The Wnt inhibitor dickkopf-1: A novel target of the mevalonate pathway in the bone cancer dialogue

✍ T.D. Rachner⁎; E. Tsourdi; P. Hadji; L.C. Hofbauer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 72 KB

HMGB1 as a mediator of necrosis-induced

HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis

✍ Andersson, Ulf; Tracey, Kevin J 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Restoring impaired protein metabolism in

Restoring impaired protein metabolism in Parkinson's disease - TFEB-mediated autophagy as a novel therapeutic target

✍ Ebrahimi-Fakhari, Darius; Wahlster, Lara 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

The effect of zoledronic acid on serum D

The effect of zoledronic acid on serum Dickkopf-1, osteoprotegerin and rankl in patients with paget's disease of bone

✍ S.A. Polyzos; A.D. Anastasilakis; Z. Efstathiadou; M. Kita; I. Litsas; A. Avrami 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The bone morphogenetic protein–hepcidin

The bone morphogenetic protein–hepcidin axis as a therapeutic target in inflammatory bowel disease

✍ Lijian Wang; Estela Trebicka; Ying Fu; Shiri Ellenbogen; Charles C. Hong; Jodie 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 527 KB

Background: A debilitating anemia associated with low serum iron often accompanies inflammatory bowel disease (IBD). Increased production of the iron regulatory hormone hepcidin is implicated in its pathogenesis and may also contribute to the inflammatory process itself. Hepcidin expression is depen